Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis

References

• Zang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–369.
   PubMed Web of Science ®Google Scholar
• Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26–35.
   PubMed Web of Science ®Google Scholar
• Allen K, Golightly Y. Epidemiology of osteoarthritis: state of the evidence. Curr Opin Rheumatol. 2015;27:276–283.
   PubMed Web of Science ®Google Scholar
• Hochberg M. Osteoarthritis. In: Silman A, Hochberg M, eds. Epidemiology of the Rheumatic Diseases. Oxford, UK: Oxford University Press; 2001:206–229.
   Google Scholar
• Wollheim FA, Lohmander LS. Pathogenesis and pathology of osteoarthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 4th ed. St. Louis, MO: Mosby Elsevier; 2008:1711–1728.
   Google Scholar
• Hochberg MC. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Cur Top Med Chem. 2005;5:443–448.
   PubMed Web of Science ®Google Scholar
• Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–1175.
   PubMed Web of Science ®Google Scholar
• Bookman AAM, Williams KS, Shainhouse JZ, et al. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171:333–338.
   PubMed Web of Science ®Google Scholar
• Tugwell PS, Wells GA, Stainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31:2002–2012.
   PubMed Web of Science ®Google Scholar
• Shaible HG. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep. 2012;14:549–556.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388.
   PubMed Web of Science ®Google Scholar
• Kean WF, Kean R, Buchanan WW. Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology. 2004;12:3–31.
   PubMedGoogle Scholar
• Alshami AM. Knee osteoarthritis related pain: a narrative review of diagnosis and treatment. Int J Health Sci (Qassim). 2014;8:85–104.
   PubMedGoogle Scholar
• Hui X, Hewitt PG, Poblete N, et al. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteer. Pharm Res. 1998;15:1589–1595.
   PubMed Web of Science ®Google Scholar
• Van Walsem V, Pandhi S, Nixon RM, et al. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arthritis Res Ther. 2015;17:66.
   PubMed Web of Science ®Google Scholar
• Roth S. Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. J Pain Res. 2011;4:159–167.
   PubMedGoogle Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26:1715–1731.
   PubMed Web of Science ®Google Scholar
• Fowler PD, Shadforth MF, Crook PR, John VA. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur J Clin Pharmacol. 1983;25:389–394.
   PubMed Web of Science ®Google Scholar
• Nair B. A review of topical diclofenac use in musculoskeletal disease. Pharmaceuticals. 2010;3:1892–1908.
   Google Scholar
• Holt RJ. Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers. Postgrad Med 2015;127:581–590.
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals Voltaren Monograph. Novartis Web site. https://www.novartis.ca/sites/www.novartis.ca/files/voltaren_scrip_e.pdf. Last accessed November 13, 2016.
   Google Scholar
• Lee S, Simon A. Efficacy and safety of topical diclofenac containing dimethylsulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;14:238–245.
   Google Scholar
• Heyneman C, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60:555–574.
   PubMed Web of Science ®Google Scholar
• Altman R, Bosch B, Brune K, Patrignani P, Young C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs. 2015;75:859–877.
   PubMed Web of Science ®Google Scholar
• Dehghanyar P. Topical skin penetration of diclofenac after single- and multiple-dose application. Int J Clin Pharmacol Ther. 2004;42:353–359.
   PubMed Web of Science ®Google Scholar
• Yarishkin OV. Diclofenac, a non-steroidal anti-inflammatory drug, inhibits L-type Ca channels in neonatal rat ventricular cardiomyocytes. Korean J Physiol Pharmacol. 2009;13:437–442.
   PubMed Web of Science ®Google Scholar
• Hotchberg M. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64:465–474.
   Web of Science ®Google Scholar
• Bruyere O. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263.
   PubMed Web of Science ®Google Scholar
• Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;(4): CD007400.
   Web of Science ®Google Scholar
• Zhang W, Zhang W, Jones A, Doherty M. Efficacy of topical nonsteroidal anti- inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329:324–326.
   PubMedGoogle Scholar
• Mason L, Moore RA, Edwards JE, Derry S, McQuay H. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskel Disord. 2004;5:28.
   PubMed Web of Science ®Google Scholar
• Taylor RS, Fotopoulos G, Malbach H. Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions. Curr Med Res Opin. 2011;27:605–622.
   PubMed Web of Science ®Google Scholar
• Roth SH. Nonsteroidal anti-inflammatory drug gastropathy. We started it—can we stop it. Arch Intern Med. 1986;146:1075–1076.
   Google Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331–1346.
   PubMed Web of Science ®Google Scholar
• Emery P, Zeidler H, Kvien TK, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet. 1999;354:2106–2111.
   PubMed Web of Science ®Google Scholar
• Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis. 2010;69:1453–1458.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions. Osteoarthritis: National Clinical Guideline for Care and Management in Adults. London: Royal College of Physicians; 2008. http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf. Accessed May 5, 2010.
   Google Scholar